Journal ArticleOPEN ACCESS

Unleashing the tiger – iatrogenic autoimmunity from cancer immunotherapy drugs

  • Luu Q
  • Major G
JRSM Open (2018) 9(1)
DOI: 10.1177/2054270417746905
N/ACitations
Citations of this article
9Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Immune checkpoint inhibitors can lead to the development of organ and non-organ specific immune related adverse events.

Cite

CITATION STYLE

APA

Luu, Q., & Major, G. (2018). Unleashing the tiger – iatrogenic autoimmunity from cancer immunotherapy drugs. JRSM Open, 9(1). https://doi.org/10.1177/2054270417746905

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free